1-(3-Chloropropyl)-4-(2-Hydroxyethyl)Piperazine Industrial Purity Coa Verification
- Strict QC Protocols: Verification relies on dual-method analysis using HPLC and GC-MS to ensure industrial purity exceeds 98.5%.
- Documentation Integrity: Every batch includes a comprehensive COA detailing impurity profiles and physical constants.
- Global Supply Chain: Partner with a global manufacturer to secure stable supply for large-scale pharmaceutical production.
In the competitive landscape of fine chemical manufacturing, the consistency of organic building blocks dictates the success of downstream synthesis. 1-(3-Chloropropyl)-4-(2-hydroxyethyl)piperazine serves as a critical pharmaceutical intermediate utilized in the development of various therapeutic agents. Ensuring the structural integrity and purity of this compound is not merely a regulatory requirement but a fundamental necessity for maintaining reaction yields in subsequent steps. At NINGBO INNO PHARMCHEM CO.,LTD., we prioritize rigorous verification processes to guarantee that every shipment meets the stringent demands of industrial-scale organic synthesis.
Procurement teams must look beyond basic specifications and understand the analytical depth required to validate quality. This article details the technical standards for verification, focusing on chromatographic methods, impurity limits, and the essential documentation required for batch release.
HPLC and GC-MS Testing Standards
Accurate quantification of purity requires orthogonal analytical methods. Relying on a single technique often fails to detect specific classes of contaminants. Our quality control laboratories employ both High-Performance Liquid Chromatography (HPLC) and Gas Chromatography-Mass Spectrometry (GC-MS) to cross-verify results. HPLC is primarily used to determine the main assay content, typically targeting a minimum of 98.5% for high purity grade materials. The method utilizes a reversed-phase column with UV detection, optimized to separate the target molecule from closely related polar impurities.
Conversely, GC-MS is indispensable for identifying volatile organic compounds and residual solvents that may persist after the final distillation or crystallization step. This dual-approach ensures that the manufacturing process has effectively removed reaction by-products. For buyers evaluating suppliers, requesting raw chromatograms alongside the final report is a best practice. It provides transparency into the separation efficiency and confirms that no co-eluting peaks are masking potential contaminants.
Understanding Impurity Profiles and Limits
The chemical identity of impurities can significantly impact downstream reactivity. In the production of piperazine derivatives, common impurities include unreacted starting materials, over-alkylated species, and hydrolysis products. A robust quality specification defines strict limits for these deviations. For instance, free piperazine content is usually capped at 0.5%, while heavy metals and residual chlorides are monitored to meet international safety standards.
Understanding the synthesis route helps in predicting potential impurity profiles. If the chloropropyl chain is introduced via nucleophilic substitution, there is a risk of dichloro-propane residues. Advanced verification involves spiking samples with known impurity standards to validate the limit of detection (LOD) and limit of quantification (LOQ). By maintaining tight control over these parameters, manufacturers ensure that the chemical reagent performs predictably in complex multi-step syntheses.
Typical Specification Table
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | Colorless to Pale Yellow Liquid | Visual |
| Assay (Purity) | ≥ 98.5% | HPLC |
| Water Content | ≤ 0.5% | Karl Fischer |
| Residual Solvents | Compliant with ICH Q3C | GC-MS |
| Heavy Metals | ≤ 10 ppm | ICP-MS |
Required Documentation for Batch Release
Regulatory compliance hinges on comprehensive documentation. The Certificate of Analysis (COA) is the primary document verifying that a specific batch meets all agreed-upon specifications. However, a complete technical dossier should also include the Method of Analysis (MOA) and Stability Data. The COA must be batch-specific, displaying unique lot numbers, manufacturing dates, and retest dates. Generic certificates that lack specific analytical data points should be rejected.
Furthermore, traceability is crucial for audit purposes. Documentation should link the final product back to the raw material inputs, ensuring that the supply chain remains transparent. This level of detail supports regulatory filings for downstream pharmaceutical products. When auditing a supplier, verify that their Quality Management System (QMS) aligns with ISO standards, ensuring that every batch release undergoes independent verification before shipping.
Commercial Procurement and Supply Chain
Securing a reliable source for specialized intermediates requires partnering with an established entity capable of scaling production without compromising quality. Fluctuations in bulk price are often tied to raw material availability and energy costs, but consistent quality should never be negotiated. When sourcing high-purity 4-(3-Chloropropyl)-1-piperazine Ethanol, buyers should prioritize manufacturers who maintain safety stock and offer flexible logistics solutions.
NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier partner in this sector, offering a stable supply of critical intermediates to global markets. Our commitment to technical excellence ensures that clients receive materials that facilitate efficient synthesis routes and high final yields. By integrating rigorous COA verification with robust manufacturing capabilities, we support the long-term success of our partners’ development pipelines. For detailed technical inquiries or bulk procurement requests, our team is prepared to provide full transparency on production capabilities and quality assurance protocols.